LFG
RCKT icon

Larson Financial Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Larson Financial Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438 Hold
128
– – ﹤0.01% 3511
2026
Q1 		$458 Sell
128
-1,501
-92% -$5.97K ﹤0.01% 3327
2025
Q4 		$5.72K Buy
1,629
+1,484
+1,023% +$5.08K ﹤0.01% 2399
2025
Q3 		$473 Buy
145
+22
+18% +$69 ﹤0.01% 3120
2025
Q2 		$301 Buy
+123
New +$623 ﹤0.01% 2975

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Larson Financial Group's RCKT Position: Q2 2026 in Review

Larson Financial Group held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 128 shares worth $438. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Larson Financial Group first reported a position in RCKT in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.72K in Q4 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Larson Financial Group held 128 shares of Rocket Pharmaceuticals worth $438 as of Q2 2026.
  • Larson Financial Group left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3511 holding.
  • Larson Financial Group first reported a position in Rocket Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Rocket Pharmaceuticals position peaked at $5.72K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.